Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19369 | 444 | 47.9 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHFR | Author keyword | 75 | 80% | 11% | 47 |
2 | EPIGENETCANC | Address | 3 | 100% | 1% | 3 |
3 | P41 ARC | Author keyword | 2 | 67% | 0% | 2 |
4 | RNF180 | Author keyword | 2 | 67% | 0% | 2 |
5 | EPIGEN | Address | 2 | 12% | 4% | 16 |
6 | ABERRANT DNA METHYLATION | Author keyword | 2 | 26% | 1% | 6 |
7 | CHFR GENE | Author keyword | 1 | 100% | 0% | 2 |
8 | QUANTITATIVE METHYLATION SPECIFIC PCR Q MSP | Author keyword | 1 | 50% | 0% | 2 |
9 | POOR SURVIVAL | Author keyword | 1 | 33% | 0% | 2 |
10 | ACTIVE GASTRITIS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHFR | 75 | 80% | 11% | 47 | Search CHFR | Search CHFR |
2 | P41 ARC | 2 | 67% | 0% | 2 | Search P41+ARC | Search P41+ARC |
3 | RNF180 | 2 | 67% | 0% | 2 | Search RNF180 | Search RNF180 |
4 | ABERRANT DNA METHYLATION | 2 | 26% | 1% | 6 | Search ABERRANT+DNA+METHYLATION | Search ABERRANT+DNA+METHYLATION |
5 | CHFR GENE | 1 | 100% | 0% | 2 | Search CHFR+GENE | Search CHFR+GENE |
6 | QUANTITATIVE METHYLATION SPECIFIC PCR Q MSP | 1 | 50% | 0% | 2 | Search QUANTITATIVE+METHYLATION+SPECIFIC+PCR+Q+MSP | Search QUANTITATIVE+METHYLATION+SPECIFIC+PCR+Q+MSP |
7 | POOR SURVIVAL | 1 | 33% | 0% | 2 | Search POOR+SURVIVAL | Search POOR+SURVIVAL |
8 | ACTIVE GASTRITIS | 1 | 50% | 0% | 1 | Search ACTIVE+GASTRITIS | Search ACTIVE+GASTRITIS |
9 | ADRA1B | 1 | 50% | 0% | 1 | Search ADRA1B | Search ADRA1B |
10 | ANAPC1 | 1 | 50% | 0% | 1 | Search ANAPC1 | Search ANAPC1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MITOTIC STRESS CHECKPOINT | 52 | 77% | 8% | 36 |
2 | MITOTIC CHECKPOINT PROTEIN | 26 | 87% | 3% | 13 |
3 | STRESS CHECKPOINT | 23 | 86% | 3% | 12 |
4 | CADHERIN PROMOTER HYPERMETHYLATION | 11 | 100% | 1% | 6 |
5 | ABERRANT DNA METHYLATION | 10 | 17% | 12% | 55 |
6 | CHROMOSOMAL LOSSES | 8 | 100% | 1% | 5 |
7 | EPIGENETIC FIELD | 7 | 64% | 2% | 7 |
8 | MICROTUBULE INHIBITORS | 6 | 25% | 5% | 20 |
9 | TUMOR RELATED GENES | 6 | 28% | 4% | 18 |
10 | ABERRANT HYPERMETHYLATION | 4 | 75% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CpG Island Methylator Phenotype, Helicobacter pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis | 2014 | 6 | 36 | 42% |
Gene methylation in gastric cancer | 2013 | 49 | 236 | 13% |
Epigenetic field for cancerization | 2007 | 107 | 56 | 25% |
CHFR: a key checkpoint component implicated in a wide range of cancers | 2012 | 11 | 111 | 48% |
Epigenetic Deregulations in Gastric Cancer | 2013 | 19 | 115 | 23% |
DNA and histone methylation in gastric carcinogenesis | 2013 | 17 | 145 | 25% |
CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis | 2008 | 14 | 63 | 63% |
Promoter methylation of tumor-related genes in gastric carcinogenesis | 2012 | 20 | 128 | 28% |
Role of DNA Methylation in the Development of Diffuse-Type Gastric Cancer | 2011 | 22 | 79 | 29% |
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer | 2014 | 10 | 175 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIGENETCANC | 3 | 100% | 0.7% | 3 |
2 | EPIGEN | 2 | 12% | 3.6% | 16 |
3 | CLIN SIR RUN RUN SHAW HOSP | 1 | 50% | 0.2% | 1 |
4 | DIPARTIMENTO BIOL PATOL CELLULARE MOL L CALIFAN | 1 | 50% | 0.2% | 1 |
5 | HOSP ORG KURE MED | 1 | 50% | 0.2% | 1 |
6 | MED GENOME IL GENE EXP S CORE | 1 | 50% | 0.2% | 1 |
7 | MINIST EDUC GI ONCOL | 1 | 50% | 0.2% | 1 |
8 | MOL BIOL MORPHOL | 1 | 50% | 0.2% | 1 |
9 | MOL BIOL UNESP | 1 | 50% | 0.2% | 1 |
10 | MOL ONCOL CELL CYCLE REGULATCANC | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196783 | RASSF1A//RASSF2//RASSF1 |
2 | 0.0000165961 | RRBS//CPG ISLANDS//METHYLTRANSFERASE ACTIVITY |
3 | 0.0000155937 | SERRATED ADENOMA//SESSILE SERRATED ADENOMA//TRADITIONAL SERRATED ADENOMA |
4 | 0.0000150547 | HUMAN CYTOGENET TOXICOL GENET//C KI RAS ONCOGENE//JOAO BARROS BARRETO UNIV HOSP |
5 | 0.0000130705 | DAP KINASE//DEATH ASSOCIATED PROTEIN KINASE//DAPK |
6 | 0.0000093568 | RARRES3//TIG3//H REV107 |
7 | 0.0000092238 | COLONIC EFFLUENT//STOOL DNA//FECAL RNA |
8 | 0.0000090266 | LYMPHOEPITHELIOMA LIKE CARCINOMA//LYMPHOEPITHELIOMA//LYMPHOEPITHELIAL CARCINOMA |
9 | 0.0000089289 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |
10 | 0.0000080707 | E CADHERIN//HEREDITARY DIFFUSE GASTRIC CANCER//PROPHYLACTIC GASTRECTOMY |